1. Home
  2. HROW vs MBIN Comparison

HROW vs MBIN Comparison

Compare HROW & MBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HROW
  • MBIN
  • Stock Information
  • Founded
  • HROW 1998
  • MBIN 1990
  • Country
  • HROW United States
  • MBIN United States
  • Employees
  • HROW N/A
  • MBIN N/A
  • Industry
  • HROW Biotechnology: Pharmaceutical Preparations
  • MBIN Major Banks
  • Sector
  • HROW Health Care
  • MBIN Finance
  • Exchange
  • HROW Nasdaq
  • MBIN Nasdaq
  • Market Cap
  • HROW 1.4B
  • MBIN 1.5B
  • IPO Year
  • HROW N/A
  • MBIN 2017
  • Fundamental
  • Price
  • HROW $39.74
  • MBIN $32.25
  • Analyst Decision
  • HROW Strong Buy
  • MBIN Buy
  • Analyst Count
  • HROW 7
  • MBIN 3
  • Target Price
  • HROW $68.50
  • MBIN $40.00
  • AVG Volume (30 Days)
  • HROW 889.7K
  • MBIN 141.5K
  • Earning Date
  • HROW 11-12-2025
  • MBIN 10-27-2025
  • Dividend Yield
  • HROW N/A
  • MBIN 1.24%
  • EPS Growth
  • HROW N/A
  • MBIN N/A
  • EPS
  • HROW N/A
  • MBIN 4.55
  • Revenue
  • HROW $227,661,000.00
  • MBIN $598,079,000.00
  • Revenue This Year
  • HROW $43.92
  • MBIN $4.09
  • Revenue Next Year
  • HROW $41.32
  • MBIN $7.88
  • P/E Ratio
  • HROW N/A
  • MBIN $7.08
  • Revenue Growth
  • HROW 47.69
  • MBIN N/A
  • 52 Week Low
  • HROW $20.85
  • MBIN $27.25
  • 52 Week High
  • HROW $59.23
  • MBIN $46.78
  • Technical
  • Relative Strength Index (RSI)
  • HROW 45.21
  • MBIN N/A
  • Support Level
  • HROW $40.79
  • MBIN N/A
  • Resistance Level
  • HROW $48.79
  • MBIN N/A
  • Average True Range (ATR)
  • HROW 2.41
  • MBIN 0.00
  • MACD
  • HROW -0.87
  • MBIN 0.00
  • Stochastic Oscillator
  • HROW 11.18
  • MBIN 0.00

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About MBIN Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.

Share on Social Networks: